What Do We Know About Steroids Metabolism and ‘PK/PD Approach' in AKI and CKD Especially While on RRT - Current Status in 2014

Publisher： Karger

E-ISSN： 1421-9735|38|2|154-157

ISSN： 0253-5068

Source： Blood Purification, Vol.38, Iss.2, 2014-11, pp. : 154-157

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

AKI Biomarkers www (Who, Where, When): You Cannot Treat What You Do Not Know

By  

Blood Purification, Vol. 38, Iss. 1, 2014-11 ,pp. : I-II

Karger

Access to resources Recommend Favorite

Uremic Toxins: Do We Know Enough to Explain Uremia?

By  

Blood Purification, Vol. 26, Iss. 1, 2008-01 ,pp. : 77-81

Karger

Access to resources Recommend Favorite

Health-Related Quality of Life in End-Stage Renal Disease Patients: How Often Should We Ask and What Do We Do with the Answer?

By  

Blood Purification, Vol. 41, Iss. 1-3, 2016-01 ,pp. : 218-224

Karger

Access to resources Recommend Favorite

Lipid-Lowering Therapy in CKD: Should We Use It and in Which Patients

By  

Blood Purification, Vol. 43, Iss. 1-3, 2017-01 ,pp. : 196-199

Karger

Access to resources Recommend Favorite

Mineralocorticoid Receptor Antagonism: A Promising Therapeutic Approach to Treat Ischemic AKI

By  

Nephron, Vol. 134, Iss. 1, 2016-03 ,pp. : 10-13

Karger

Access to resources Recommend Favorite